Dectahan, Zaira Joy A.

HRN: 22-50-86  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2023
AMPICILLIN 250MG (VIAL)
01/26/2023
02/01/2023
IV
180mg
12
Neonatal Sepsis
Waiting Final Action 
01/26/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/26/2023
02/01/2023
IV
25mg
Q24
Neonatal Sepsis
Waiting Final Action 
01/26/2023
CEFOTAXIME 500MG (VIAL)
01/26/2023
02/02/2023
IV
55mg
Q12
Neonatal Sepsis
Waiting Final Action 
01/26/2023
CEFTAZIDIME 1GM (VIAL)
01/26/2023
02/02/2023
IV
55mg
Q12
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: